In 2022, DPHARM: Disruptive Innovations to Modernize Clinical Research Conference brought industry leaders together to explore three factors essential to innovation in clinical trials:
20/20 Onsite attended DPHARM 2022 to stay ahead of the curve in clinical research while fostering partnerships and innovative thinking for an improved patient experience. As we gear up for DPHARM 2023, revisit CEO Sonali Bloom’s key insights from the previous year.
One of the biggest challenges in clinical research is recognizing and addressing the patient burden.
Several sessions at DPHARM 2022 highlighted opportunities for sponsors and CROs to reduce the hassle and inconvenience of clinical trials.
Most clinical trials leave much of the burden to the patient, but considering the ‘coefficient of burden’ allows leaders to pinpoint the barriers hindering participation.
Sonali Bloom, Jess Mays, Ivan Quiroz, and Dr. David Gibson at DPHARM 2022.
Though innovation is a top priority for 20/20 Onsite, it does not come at the cost of the patient experience. Emerging technologies like AI can boost efficiency but risk sidelining person-to-person connections.
What sets 20/20 Onsite apart:
Sonali Bloom, Jessica Mays, Ivan Quiroz, and Dr. David Gibson at the 20/20 Onsite booth at DPHARM 2022.
Our Mobile Vision Clinic excels at providing care to those who would otherwise face insurmountable barriers. By delivering care directly to individuals, we eliminate many of the obstacles that patients often encounter when seeking essential treatment. This innovative approach not only generates demand but also positively influences patient behavior, resulting in improved trial retention rates.
Moreover, we are eager to partner with site networks that share our dedication to high-quality clinical care, seamless access for patients, and the advancement of medical knowledge through clinical trials. Incorporating diverse perspectives within our workforce is essential as we strive for patients to see themselves reflected in the care they receive.
Just like our Mobile Vision Clinic's innovative approach, the transformation of healthcare requires evolving not only processes and tools but also the mindset and skills of our people.
Risk is essential to innovation — and this was a key theme at DPHARM 2022. This concept has guided 20/20 Onsite from our inception. We pride ourselves on our ability to face challenges with innovative ideas. We constantly develop new solutions to support the clinical care industry by constantly asking ourselves, “What would it take to make this happen?”
Malcolm Gladwell, renowned author and DPHARM 2022 speaker, stressed how important it is to build environments where innovation thrives. Innovation is relentless in this day and age, so advancing new ideas demands some level of risk.
We recognize every organization has a unique risk tolerance. That is why we continuously examine our own boundaries. We reflect on our own risk appetite. This motivates us to create the safest environment possible for patients — allowing our business to innovate at a faster pace.
At 20/20 Onsite, we put Gladwell’s recommendation to practice every day, building spaces where innovation thrives. We constantly forge new partnerships to advance hybrid clinical care, and attending events like DPHARM every year allows us to continue expanding our network.
The power of collaborations and partnerships in advancing healthcare was another key theme at DPHARM 2022. At 20/20 Onsite, we have fully embraced this concept as a driver of innovation.
Curious how 20/20 Onsite can go the extra mile for your clinical trial? Do not miss your chance to meet our team in person at DPHARM booth #47 and attend our complimentary events:
Schedule a meeting with our team in advance and secure your spot for the Mobile Vision Clinic tour here.